Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Helen Of Troy Posts Higher Q4 Profit; Guides FY13 - Quick Facts

RELATED NEWS
Trade HELE now with 

Helen of Troy Ltd. (HELE: Quote) posted an increase in fourth quarter net income to $29.3 million or $0.92 per share from $24.38 million or $0.77 per share last year.

Sales revenue rose to $294 million from $237.07 million in the prior-year quarter.

On average, three analysts polled by Thomson Reuters expected the company to report earnings of $0.88 per share, on revenues of $289.80 million. Analysts' estimates typically exclude special items.

Going ahead, for fiscal year 2013, ending on February 28, 2013, the company forecasts net sales revenue in the range of $1.3 billion to $1.325 billion, with earnings per share in the range of $3.80 to $3.90 per share. Analysts expect earnings of $3.87 per share, on revenues of $1.27 billion.

Click here to receive FREE breaking news email alerts for Helen of Troy Limited and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks continue to show a lack of direction in mid-day trading on Tuesday following the long, holiday weekend. Even with the lackluster performance, the markets are largely holding on to the bulk of their recent gains. After reporting an unexpected drop in U.S. construction spending in the previous month, the Commerce Department released a report on Tuesday showing that construction spending rebounded by more than expected in the month of July. Activity in the U.S. manufacturing sector unexpectedly grew at an accelerated rate in the month of August, according to a report released by the Institute for Supply Management on Tuesday, with the index of activity in the sector climbing to a three-year high.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.